EUVIMEDEUVIMED entdecken
Crossref

Prevalence and In Vivo Assessment of Virulence in Shiga Toxin-Producing Escherichia coli Clinical Isolates from Greater Cairo Area

Rana Elshimy, Hamdallah Zedan, Tarek H Elmorsy, Rania Abdelmonem Khattab

Microbial Drug Resistance · 2023

DOI: 10.1089/mdr.2022.0348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Drug Resistance, 2023. Verfasst von Rana Elshimy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Egyptian Drug Authority, Giza, Egypt. Hauptthemen laut MEDLINE: Shiga-Toxigenic Escherichia coli, Escherichia coli Proteins, Escherichia coli Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Shiga toxin-producing Escherichia coli (STEC) has been identified as an important etiologic agent of human disease in Egypt.

Aims

To investigate the occurrence and describe the characterization as well as prevalence of STEC in Greater Cairo hospitals as well as molecular characterization of virulence and resistance genes.

Methods

Four hundred seventy E. coli clinical isolates were collected from eight hospitals and analyzed by genotypic and phenotypic methods for STEC, followed by histopathological examination and scoring of different organs lesions.

Results

The highest proportion of isolates was from urine (151 isolates), whereas the lowest was from splenic drain (3 isolates). In tandem, when serogrouping was performed, 15 serogroups were obtained where the most prevalent was O157 and the least prevalent was O151. All isolates were positive when screened for identity gene gad A, while only typable strains were screened for seven virulence genes stx 1 (gene encoding Shiga toxin 1), stx 2 (gene encoding Shiga toxin 2), tsh (gene encoding thermostable hemagglutinin), eae A (gene encoding intimin), invE (gene encoding invasion protein), aggR (gene encoding aggregative adherence transcriptional regulator), and ast A (aspartate transaminase) where the prevalence was 48%, 30%, 50%, 57%, 7.5%, 12%, and 58%, respectively. Of 254 typable isolates, 152 were STEC carrying stx 1 or stx 2 genes or both.

Conclusions

Relying on in vivo comparison between different E. coli pathotypes via histopathological examination of different organs, E. coli pathotypes could be divided into mild virulent, moderate virulent, and high virulent strains. Statistical analysis revealed significant correlation between different serogroups and presence of virulence genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shiga-Toxigenic Escherichia coliEscherichia coli ProteinsEscherichia coli InfectionsHumansVirulencePrevalenceAnti-Bacterial AgentsMicrobial Sensitivity TestsVirulence FactorsFeces

Stichwörter der Autor:innen

EgyptEscherichia coliO157STEChospitalsvirulence

Substanzen

Escherichia coli ProteinsAnti-Bacterial AgentsVirulence Factors

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Egyptian Drug Authority, Giza, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Zitieren

APA

Elshimy, R., Zedan, H., Elmorsy, T. H., & Khattab, R. A. (2023). Prevalence and In Vivo Assessment of Virulence in Shiga Toxin-Producing Escherichia coli Clinical Isolates from Greater Cairo Area. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2022.0348

Vancouver

Elshimy R, Zedan H, Elmorsy TH, Khattab RA. Prevalence and In Vivo Assessment of Virulence in Shiga Toxin-Producing Escherichia coli Clinical Isolates from Greater Cairo Area. Microbial Drug Resistance. 2023. doi:10.1089/mdr.2022.0348

BibTeX
@article{Elshimy2023,
  author = {Elshimy, Rana and Zedan, Hamdallah and Elmorsy, Tarek H and Khattab, Rania Abdelmonem},
  title = {Prevalence and In Vivo Assessment of Virulence in Shiga Toxin-Producing Escherichia coli Clinical Isolates from Greater Cairo Area},
  journal = {Microbial Drug Resistance},
  year = {2023},
  doi = {10.1089/mdr.2022.0348}
}
Kostenlos starten →